Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events.
Edoardo MannucciMarco GalloAndrea GiaccariRiccardo CandidoBasilio PintaudiGiovanni TargherMatteo Monaminull nullPublished in: Diabetes, obesity & metabolism (2022)
The results of this updated meta-analysis need to be considered in the choice of drug treatment for type 2 diabetes mellitus, which cannot be merely based on the effect of glucose-lowering drugs on long-term glycaemic control.